Imaging stem cell implant for cellular-based therapies

Experimental Biology and Medicine

Volumn 233, Issue 8, 2008, Pages 930-940

  Lee, Zhenghong ^a   Dennis, James E ^b   Gerson, Stanton L ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioluminescent imaging; Cell based therapy; Hematopoietic stem cell; Mesenchymal stem cell; Positron emission tomography; Stem cell imaging

Indexed keywords

8 QUINOLINOL INDIUM IN 111; CARMUSTINE; FIREFLY LUCIFERASE; FLUOROURACIL; IODINE 123; IODINE 125; IODINE 131; PERTECHNETIC ACID TC 99M; TEMOZOLOMIDE; COTRANSPORTER; DIAGNOSTIC AGENT; INDIUM; RADIOPHARMACEUTICAL AGENT; SODIUM IODIDE SYMPORTER;

ADVANCED CANCER; BIOLUMINESCENCE; BONE MARROW CELL; BRAIN TUMOR; CELL DIFFERENTIATION; CELL LABELING; CELL MIGRATION; CELL SURVIVAL; CELL THERAPY; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; IMAGING SYSTEM; MOLECULAR IMAGING; NIS GENE; NON INVASIVE PROCEDURE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; REPORTER GENE; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL; STEM CELL TRANSPLANTATION; ANIMAL; CELL MOTION; CYTOLOGY; GENETICS; LUMINESCENCE; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; REVIEW; SCINTISCANNING;

ANIMALIA;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SURVIVAL; GENES, REPORTER; HUMANS; INDIUM RADIOISOTOPES; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; MICE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STEM CELL TRANSPLANTATION; STEM CELLS; SYMPORTERS;

EID: 50649102179     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0709-MR-234     Document Type: Short Survey

References (78)

1. Bertz H, Illerhaus G, Veelken H, Finke J. Allogeneic hematopoietic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens. Ann Oncol 13:135-139, 2002.
2. Gratwohl A, Baldomero H, Demirer T, Rosti G, Dini G, Ladenstein R, Urbano-Ispizua A. Hematopoetic stem cell transplantation for solid tumors in Europe. Ann Oncol 15:653-660, 2004.
3. Haynesworth S, Goshima J, Goldberg V, Caplan A. Characterization of cells with osteogenic potential from human marrow. Bone 13:81-88, 1992.
4. Pittinger M, Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J, Moorman M, Simonetti D, Craig S, Marshak D. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147, 1999.
5. Caplan A. Mesenchymal stem cells. J Orthop Res 9:641-650, 1991.
6. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101:2999-3001, 2003.
7. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesen- chymal stem cells in advanced breast cancer patients receiving high- dose chemotherapy. J Clin Oncol 18:307-316, 2000.
8. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR Jr, Moseley AB, Bacigalupo A. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11:389-398, 2005.
9. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441, 2004.
10. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang FF. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307-3318, 2005.
11. Daley GQ, Goodell MA, Snyder EY. Realistic prospects for stem cell therapeutics. Hematol Am Soc Hematol Educ Program 398-418, 2003.
12. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, Katakowski M, Zhang LJ, Lu M, Janakiraman N, Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59:514-523, 2002.
13. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104:1217-23, 2004.
14. Bulte JW, Arbab AS, Douglas T, Frank JA. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Methods Enzymol 386:275-299, 2004.
15. Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, Nolta JA, Caruthers SD, Lanza GM, Wickline SA. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. Faseb J 21:1647-1654, 2007.
16. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, Ganser A, Knapp WH, Drexler H. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111:2198-2202, 2005.
17. Ma B, Hankenson KD, Dennis JE, Caplan AI, Goldstein SA, Kilbourn MR. A simple method for stem cell labeling with fluorine 18. Nucl Med Biol 32:701-705, 2005.
18. Bindslev L, Haack-Sorensen M, Bisgaard K, Kragh L, Mortensen S, Hesse B, Kjaer A, Kastrup J. Labelling of human mesenchymal stem cells with indium-111 for SPECT imaging: effect on cell proliferation and differentiation. Eur J Nucl Med Mol Imaging, 2006.
19. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169:12-20, 2001.
20. Jin Y, Kong H, Stodilka RZ, Wells RG, Zabel P, Merrifield PA, Sykes J, Prato FS. Determining the minimum number of detectable cardiac-transplanted 111In-tropolone-labelled bone-marrow-derived mesenchy-mal stem cells by SPECT. Phys Med Biol 50:4445-4455, 2005.
21. Brenner W, Aicher A, Eckey T, Massoudi S, Zuhayra M, Koehl U, Heeschen C, Kampen WU, Zeiher AM, Dimmeler S, Henze E. 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 45:512-518, 2004.
22. Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, Assmus B, Eckey T, Henze E, Zeiher AM, Dimmeler S. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107:2134-2139, 2003.
23. Bettin K, Allen MO, Gerding DN, Forstrom L, Shafer R. In-111 Pseudomonas aeruginosa: a simple method of labeling live bacteria with a gamma-emitting radioisotope. Eur J Nucl Med 12:277-279, 1986.
24. Mangi A, Noiseux N, Kong D, He H, Rezvani M, Ingwall J, Dzau V. Mesenchymal stem cells genetically modified with AKT prevent remodeling and restore performance of infarcted hearts. Nature Med 9:1195-1201, 2003.
25. Min JJ, Ahn Y, Moon S, Kim YS, Park JE, Kim SM, Le UN, Wu JC, Joo SY, Hong MH, Yang DH, Jeong MH, Song CH, Jeong YH, Yoo KY, Kang KS, Bom HS. In vivo bioluminescence imaging of cord blood derived mesenchymal stem cell transplantation into rat myocardium. Ann Nucl Med 20:165-170, 2006.
26. Pelled G, Tai K, Sheyn D, Zilberman Y, Kumbar S, Nair LS, Laurencin CT, Gazit D, Ortiz C. Structural and nanoindentation studies of stem cell-based tissue-engineered bone. J Biomech, 2006.
27. Hung SC, Deng WP, Yang WK, Liu RS, Lee CC, Su RC, Lin RJ, Yang DM, Chang CW, Chen WH, Wei HJ, Gelovani JG. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 11:7749-7756, 2005.
28. Bai JZ, Ding WM, Liu ZJ, Yu MJ, Tian JH, Wang F, Du J, Zhang XY, Li LS, Shen L. [Transferrin receptor expression of human mesenchymal stem cells and in vitro tracking by autoradiography after transplantation in spinal cord]. Beijing Da Xue Xue Bao 36:276-280, 2004.
29. van Dyke K, van Dyke C, Woodfork K. Luminescence Biotechnology: Instruments and applications. Boca Raton, FL: CRC Press, 2002.
30. Bushberg JT, Seibert JA, Leidholdt J, Boone EM, Boone JM. The Essential Physics of Medical Imaging, 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2002.
31. Valk PE, Bailey DL, Townsend DW, Maisey MN. Positron Emission Tomography: Basic science and clinical practice. London: Springer-Verlag, 2003.
32. Kalish H, Arbab AS, Miller BR, Lewis BK, Zywicke HA, Bulte JW, Bryant LH Jr, Frank JA. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med 50:275-282, 2003.
33. Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JW. Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 54:769-774, 2005.
34. Zhou R, Acton PD, Ferrari VA. Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol 48:2094-2106, 2006.
35. Lennon DP, Haynesworth SE, Bruder SP, Jaiswal N, Caplan AI. Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation. In Vitro Cell Dev Biol 32:602-611, 1996.
36. DeLuca M, McElroy WD. Kinetics of the firefly luciferase catalyzed reactions. Biochemistry 13:921-925, 1974.
37. Cook SH, Griffin DE. Luciferase imaging of a neurotropic viral infection in intact animals. J Virol 77:5333-5338, 2003.
38. Hardy J, Francis KP, DeBoer M, Chu P, Gibbs K, Contag CH. Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science 303:851-853, 2004.
39. Luker GD, Pica CM, Song J, Luker KE, Piwnica-Worms D. Imaging 26S proteasome activity and inhibition in living mice. Nat Med 9:969-973, 2003.
40. Paulmurugan R, Umezawa Y, Gambhir SS. Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies. Proc Natl Acad Sci U S A 99:15608-15613, 2002.
41. Sarraf-Yazdi S, Mi J, Dewhirst MW, Clary BM. Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice. J Surg Res 120:249-255, 2004.
42. Wetterwald A, van der Pluijm G, Que I, Sijmons B, Buijs J, Karperien M, Lowik CW, Gautschi E, Thalmann GN, Cecchini MG. Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 160:1143-1153, 2002.
43. Zhang GJ, Safran M, Wei W, Sorensen E, Lassota P, Zhelev N, Neuberg DS, Shapiro G, Kaelin WG, Jr. Bioluminescent imaging of Cdk2 inhibition in vivo. Nat Med 10:643-648, 2004.
44. Cao YA, Wagers AJ, Beilhack A, Dusich J, Bachmann MH, Negrin RS, Weissman IL, Contag CH. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A 101:221-226, 2004.
45. Lin Y, Cheung P, Wilson DL, Gerson SJ. Visualization of enhanced clonal expansion bioluminescence imaging. Mol Imaging 3:282, 2004.
46. Jaffee EM, Dranoff G, Cohen LK, Hauda KM, Clift S, M. F. F, Mulligan RC, Pardoll DC. High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res 53:2221, 1993.
47. de Felipe P, Hughes LE, Ryan MD, Brown JD. Co-translational, intraribosomal cleavage of polypeptides by the foot-and-mouth disease virus 2A peptide. J Biol Chem 278:11441-11448, 2003.
48. Donnelly ML, Hughes LE, Luke G, Mendoza H, ten Dam R, Gani F, Ryan MF. The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J Gen Virol 82:1027-1041, 2001.
49. Davis BM, Koc ON, Gerson SL. Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection. Blood 95:3078-3084, 2000.
50. Chang SM, Theodosopoulos P, Lamborn K, Malec M, Rabbitt J, Page M, Prados MD. Temozolomide in the treatment of recurrent malignant glioma. Cancer 100:605-611, 2004.
51. Sawai N, Zhou S, Vanin EF, Houghton P, Brent TP, Sorrentino BP. Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector. Mol Ther 3:78-87, 2001.
52. Niu G, Gaut AW, Ponto LL, Hichwa RD, Madsen MT, Graham MM, Domann FE. Multimodality noninvasive imaging of gene transfer using the human sodium iodide symporter. J Nucl Med 45:445-449, 2004.
53. La Perle KM, Shen D, Buckwalter TL, Williams B, Haynam A, Hinkle G, Pozderac R, Capen CC, Jhiang SM. In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer. Prostate 50:170-178, 2002.
54. Zuckier LS, Dohan O, Li Y, Chang CJ, Carrasco N, Dadachova E. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo. J Nucl Med 45:500-507, 2004.
55. Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 43:1188-1200, 2002.
56. Lee Z, Koc ON, Wojtkiewicz GR, Maitra B, Gerson SL. In vitro evaluation of imaging potential of mesenchymal stem cell transplant following NIS transfer. Mol Imaging 2:284, 2003.
57. Lee Z, Koc ON, Wojtkiewicz GR, Maitra B, Faulhaber PF, Gerson SL. Imaging mesenchymal stem cell transplant on small animal models. J Nucl Med 45:196, 2004.
58. Tournoy KG, Depraetere S, Pauwels RA, Leroux-Roels GG. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice. Clin Exp Immunol 119:231-239, 2000.
59. Kim YH, Lee DS, Kang JH, Lee YJ, Chung JK, Roh JK, Kim SU, Lee MC. Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking. J Nucl Med 46:305-311, 2005.
60. Wu JC, Wang D, Chen IY, Park JM, Patel MR, Gheyens O, Tseng JR, Gambhir SS. Molecular mechanism of reporter gene silencing and reversal in cell transplant imaging. Mol Imaging Biol 7:107, 2005.
61. Ray P, De A, Min JJ, Tsien RY, Gambhir SS. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64:1323-1330, 2004.
62. Cao F, Lin S, Xie X, Ray P, Patel M, Zhang X, Drukker M, Dylla SL, Connolly AJ, Chen X, Weissman IL, Gambhir SS, Wu JC. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113:1005-1014, 2006.
63. Wu JC, Spin JM, Cao F, Lin S, Xie X, Gheysens O, Chen IY, Sheikh AY, Robbins RC, Tsalenko A, Gambhir SS, Quertermous T. Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation. Physiol Genomics 25:29-38, 2006.
64. Ponomarev V, Doubrovin M, Serganova I, Vider J, Shavrin A, Beresten T, Ivanova A, Ageyeva L, Tourkova V, Balatoni J, Bornmann W, Blasberg R, Gelovani Tjuvajev J. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging 31:740-751, 2004.
65. Krishnan M, Park JM, Cao F, Wang D, Paulmurugan R, Tseng JR, Gonzalgo ML, Gambhir SS, Wu JC. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. Faseb J 20:106-108, 2006.
66. Dennis JE, Haynesworth SE, Young RG, Caplan AI. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant 1:23-32, 1992.
67. Love Z, Wang F, Dennis JE, Awadallah A, Salem N, Lin Y, Wiesenberger A, Majewski S, Gerson SL, Lee Z. Imaging of mesenchymal stem cell transplant by bioluminescence and PET. J Nucl Med (in press).
68. Qi H, Aguiar DJ, Williams SM, La Pean A, Pan W, Verfaillie CM. Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci U S A 100: 3305-3310, 2003.
69. Kalajzic I, Staal A, Yang WP, Wu Y, Johnson SE, Feyen JH, Krueger W, Maye P, Yu F, Zhao Y, Kuo L, Gupta RR, Achenie LE, Wang HW, Shin DG, Rowe DW. Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem 280:24618-24626, 2005.
70. Wang F, Awadallah A, Solchaga LA, Kuang Y, Salem N, Lin Y, Kim YH, Love Z, Dennis JE, Gerson SL, Lee Z. Transcription profiling of reporter genes used for molecular imaging of human mesenchymal stem cells. In: Adult Mesenchymal Stem Cells in Regenerative Medicine. Cleveland, OH: 2007.
71. Su H, Forbes A, Gambhir SS, Braun J. Quantitation of cell number by a positron emission tomography reporter gene strategy. Mol Imaging Biol 6:139-148, 2004.
72. Kang JH, Lee DS, Paeng JC, Lee JS, Kim YH, Lee YJ, Hwang DW, Jeong JM, Lim SM, Chung JK, Lee MC. Development of a sodium/iodide symporter (NIS)-transgenic mouse for imaging of cardiomyocyte-specific reporter gene expression. J Nucl Med 46:479-483, 2005.
73. Kim YH, Dennis JE, Gerson SL, Lee Z. Evaluation of stem cell differentiation by in vivo imaging. Mol Imaging 6, 2007.
74. National Institutes of Health. Stem Cell Markers. U.S. Department of Health and Human Services, 2006. Available at 〈http://stemcells.nih.gov/ info/scireport/appendixe〉
75. Pituch-Noworolska A, Majka M, Janowska-Wieczorek A, Baj-Krzyworzeka M, Urbanowicz B, Malec E, Ratajczak MZ. Circulating CXCR4-positive stem/progenitor cells compete for SDF-1-positive niches in bone marrow, muscle and neural tissues: an alternative hypothesis to stem cell plasticity. Folia Histochem Cytobiol 41:13-21, 2003.
76. Ratajczak MZ, Majka M, Kucia M, Drukala J, Pietrzkowski Z, Peiper S, Janowska-Wieczorek A. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 21:363-371, 2003.
77. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, Ben-Hur H, Many A, Lapidot T. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283:845-848, 1999.
78. Neuss S, Becher E, Woltje M, Tietze L, Jahnen-Dechent W. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells 22:405-414, 2004.